{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:51:01Z","timestamp":1794289861890,"version":"4.9.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research at Qassim University","award":["QU-APC-2025"],"award-info":[{"award-number":["QU-APC-2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29772-y","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:07:03Z","timestamp":1764583623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aloesin alleviates imiquimod-induced psoriasis in dermal layers through inhibition of interleukins and NF-\u03baB signaling pathways"],"prefix":"10.1038","volume":"16","author":[{"given":"Tariq G.","family":"Alsahli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Saad","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattam Khulaif","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"ALQahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Sayyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"29772_CR1","unstructured":"de Alcantara, C. C., Reiche, E. M. V. & Sim\u00e3o, A. N. C. In: Advances in Clinical Chemistry Vol. 100 (ed Gregory S. Makowski) 171\u2013204 (Elsevier, 2021)."},{"key":"29772_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.clindermatol.2007.08.007","volume":"25","author":"JE Gudjonsson","year":"2007","unstructured":"Gudjonsson, J. E. & Elder, J. T. Psoriasis: Epidemiology. Clin. Dermatol. 25, 535\u2013546. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.08.007 (2007).","journal-title":"Clin. Dermatol."},{"key":"29772_CR3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo, J. et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct. Target. Ther. 8, 437 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"29772_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4082\/kjfm.20.0053","volume":"42","author":"A Martinez-Moreno","year":"2020","unstructured":"Martinez-Moreno, A., Ocampo-Candiani, J. & Garza-Rodriguez, V. Psoriasis and cardiovascular disease: A narrative review. Korean J. Fam. Med. 42, 345 (2020).","journal-title":"Korean J. Fam. Med."},{"key":"29772_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"I Michalek","year":"2017","unstructured":"Michalek, I., Loring, B. & John, S. A systematic review of worldwide epidemiology of psoriasis. J. Eur. Acad. Dermatol. Venereol. 31, 205\u2013212 (2017).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"29772_CR6","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3390\/nu14142970","volume":"14","author":"MC Buha\u0219","year":"2022","unstructured":"Buha\u0219, M. C. et al. Gut microbiota in psoriasis. Nutrients 14, 2970 (2022).","journal-title":"Nutrients"},{"key":"29772_CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/ijms19020530","volume":"19","author":"M-A Boutet","year":"2018","unstructured":"Boutet, M.-A., Nerviani, A., Gallo Afflitto, G. & Pitzalis, C. Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: The clinical importance of its divergence in skin and joints. Int. J. Mol. Sci. 19, 530 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11154-016-9381-0","volume":"17","author":"K Wolk","year":"2016","unstructured":"Wolk, K. & Sabat, R. Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations. Rev. Endocr. Metab. Disord. 17, 305\u2013317. https:\/\/doi.org\/10.1007\/s11154-016-9381-0 (2016).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"29772_CR9","doi-asserted-by":"crossref","unstructured":"Walvekar, K. P. et al. Biochanin A Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Modulating the NF-\u03baB and MAPK Signaling Pathways. Inflammation, 1\u201318 (2024).","DOI":"10.1007\/s10753-024-02103-5"},{"key":"29772_CR10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.amjcard.2016.05.060","volume":"118","author":"EJ Armstrong","year":"2016","unstructured":"Armstrong, E. J. & Krueger, J. G. Lipoprotein metabolism and inflammation in patients with psoriasis. Am. J. Cardiol. 118, 603\u2013609 (2016).","journal-title":"Am. J. Cardiol."},{"key":"29772_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169063","author":"S Piaserico","year":"2022","unstructured":"Piaserico, S., Orlando, G. & Messina, F. Psoriasis and cardiometabolic diseases: shared genetic and molecular pathways. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23169063 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2023.06.007","volume":"161","author":"A Shahi","year":"2023","unstructured":"Shahi, A. et al. Potential roles of inflammasomes in the pathophysiology of psoriasis: A comprehensive review. Mol. Immunol. 161, 44\u201360 (2023).","journal-title":"Mol. Immunol."},{"key":"29772_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0001-7310(14)70014-6","volume":"105","author":"A Chiricozzi","year":"2014","unstructured":"Chiricozzi, A. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis. Actas Dermosifiliogr. 105, 9\u201320. https:\/\/doi.org\/10.1016\/S0001-7310(14)70014-6 (2014).","journal-title":"Actas Dermosifiliogr."},{"key":"29772_CR14","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14712598.2015.1084284","volume":"15","author":"A Alunno","year":"2015","unstructured":"Alunno, A. et al. Targeting the IL-23\/IL-17 axis for the treatment of psoriasis and psoriatic arthritis. Expert Opin. Biol. Ther. 15, 1727\u20131737 (2015).","journal-title":"Expert Opin. Biol. Ther."},{"key":"29772_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10753-013-9715-y","volume":"37","author":"J-Q Hao","year":"2014","unstructured":"Hao, J.-Q. Targeting interleukin-22 in psoriasis. Inflammation 37, 94\u201399 (2014).","journal-title":"Inflammation"},{"key":"29772_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt, A. & Chiricozzi, A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin. Rev. Allergy Immunol. 55, 379\u2013390. https:\/\/doi.org\/10.1007\/s12016-018-8702-3 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"29772_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clim.2018.09.002","volume":"206","author":"CT Nguyen","year":"2019","unstructured":"Nguyen, C. T., Bloch, Y., Sk\u0142adanowska, K., Savvides, S. N. & Adamopoulos, I. E. Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight. Clin. Immunol. (Orlando) 206, 15\u201322. https:\/\/doi.org\/10.1016\/j.clim.2018.09.002 (2019).","journal-title":"Clin. Immunol. (Orlando)"},{"key":"29772_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz, A. M., Au, S. C., Kim, N., Gottlieb, A. B. & Lizzul, P. F. NF-\u03baB: An essential transcription factor in psoriasis. J. Dermatol. Sci. 69, 89\u201394. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.11.002 (2013).","journal-title":"J. Dermatol. Sci."},{"key":"29772_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12011-012-9479-5","volume":"150","author":"M Naz\u0131ro\u011flu","year":"2012","unstructured":"Naz\u0131ro\u011flu, M., Y\u0131ld\u0131z, K., Tamt\u00fcrk, B., Erturan, \u0130 & Flores-Arce, M. Selenium and psoriasis. Biol. Trace Elem. Res. 150, 3\u20139. https:\/\/doi.org\/10.1007\/s12011-012-9479-5 (2012).","journal-title":"Biol. Trace Elem. Res."},{"key":"29772_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411662","author":"BW Lee","year":"2023","unstructured":"Lee, B. W. & Moon, S. J. Inflammatory cytokines in psoriatic arthritis: Understanding pathogenesis and implications for treatment. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241411662 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/biology10111121","volume":"10","author":"SA Rashid","year":"2021","unstructured":"Rashid, S. A. et al. Olive oil based methotrexate loaded topical nanoemulsion gel for the treatment of imiquimod induced psoriasis-like skin inflammation in an animal model. Biology 10, 1121 (2021).","journal-title":"Biology"},{"key":"29772_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/1744666X.2015.1026894","volume":"11","author":"O Y\u00e9lamos","year":"2015","unstructured":"Y\u00e9lamos, O. & Puig, L. Systemic methotrexate for the treatment of psoriasis. Expert Rev. Clin. Immunol. 11, 553\u2013563. https:\/\/doi.org\/10.1586\/1744666X.2015.1026894 (2015).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"29772_CR23","doi-asserted-by":"crossref","unstructured":"Agrawal, Y. O., Mahajan, U. B., Mahajan, H. S. & Ojha, S. Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: formulation, optimization, characterization, in-vitro and in-vivo studies. Int. J. Nanomed., 4763\u20134778 (2020).","DOI":"10.2147\/IJN.S247007"},{"key":"29772_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jid.2009.252","volume":"130","author":"G Han","year":"2010","unstructured":"Han, G. et al. A role for TGF\u03b2 signaling in the pathogenesis of psoriasis. J. Investig. Dermatol. 130, 371\u2013377. https:\/\/doi.org\/10.1038\/jid.2009.252 (2010).","journal-title":"J. Investig. Dermatol."},{"key":"29772_CR25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10715762.2019.1648800","volume":"53","author":"SP Cannavo","year":"2019","unstructured":"Cannavo, S. P., Riso, G., Casciaro, M., Di Salvo, E. & Gangemi, S. Oxidative stress involvement in psoriasis: A systematic review. Free Radical Res. 53, 829\u2013840 (2019).","journal-title":"Free Radical Res."},{"key":"29772_CR26","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.3390\/ijms14059126","volume":"14","author":"FA Wagener","year":"2013","unstructured":"Wagener, F. A., Carels, C. E. & Lundvig, D. M. Targeting the redox balance in inflammatory skin conditions. Int. J. Mol. Sci. 14, 9126\u20139167 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/092986707780059625","volume":"14","author":"M Schon","year":"2007","unstructured":"Schon, M. & Schon, M. P. The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr. Med. Chem. 14, 681\u2013687 (2007).","journal-title":"Curr. Med. Chem."},{"key":"29772_CR28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ijd.13235","volume":"55","author":"E Hanna","year":"2016","unstructured":"Hanna, E., Abadi, R. & Abbas, O. Imiquimod in dermatology: An overview. Int. J. Dermatol. 55, 831\u2013844 (2016).","journal-title":"Int. J. Dermatol."},{"key":"29772_CR29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2165\/00003495-200666130-00001","volume":"66","author":"C Woodmansee","year":"2006","unstructured":"Woodmansee, C., Pillow, J. & Skinner, R. B. The role of topical immune response modifiers in skin cancer. Drugs 66, 1657\u20131664 (2006).","journal-title":"Drugs"},{"key":"29772_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12367","volume":"41","author":"A Ueyama","year":"2014","unstructured":"Ueyama, A. et al. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: A role for interferon-alpha in dendritic cell activation by imiquimod. J. Dermatol. 41, 135\u2013143 (2014).","journal-title":"J. Dermatol."},{"key":"29772_CR31","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1055\/s-2002-35666","volume":"68","author":"A Yagi","year":"2002","unstructured":"Yagi, A. et al. Antioxidant, free radical scavenging and anti-inflammatory effects of aloesin derivatives in Aloe vera. Planta Med. 68, 957\u2013960. https:\/\/doi.org\/10.1055\/s-2002-35666 (2002).","journal-title":"Planta Med."},{"key":"29772_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.lfs.2011.01.010","volume":"88","author":"MY Park","year":"2011","unstructured":"Park, M. Y., Kwon, H. J. & Sung, M. K. Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model. Life Sci. 88, 486\u2013492. https:\/\/doi.org\/10.1016\/j.lfs.2011.01.010 (2011).","journal-title":"Life Sci."},{"key":"29772_CR33","first-page":"19","volume":"28","author":"HM Wahedi","year":"2017","unstructured":"Wahedi, H. M. et al. Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK\/Rho and Smad signaling pathways in vitro and in vivo. Phytomed. Int. J. Phytother. Phytopharmacol. 28, 19\u201326 (2017).","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"29772_CR34","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. Plos Biol. 18, e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","journal-title":"Plos Biol."},{"key":"29772_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114064","volume":"148","author":"SS Alqarni","year":"2025","unstructured":"Alqarni, S. S. et al. Exploring acemannan-loaded nanogel formulation for the treatment of IMQ-induced psoriasis-like inflammation: In vitro characterization and in vivo efficacy assessment. Int. Immunopharmacol. 148, 114064. https:\/\/doi.org\/10.1016\/j.intimp.2025.114064 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"29772_CR36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40257-020-00521-3","volume":"21","author":"SA Svoboda","year":"2020","unstructured":"Svoboda, S. A., Ghamrawi, R. I., Owusu, D. A. & Feldman, S. R. Treatment goals in psoriasis: Which outcomes matter most?. Am. J. Clin. Dermatol. 21, 505\u2013511 (2020).","journal-title":"Am. J. Clin. Dermatol."},{"key":"29772_CR37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/children8111057","volume":"8","author":"KA Kelly","year":"2021","unstructured":"Kelly, K. A., Balogh, E. A., Kaplan, S. G. & Feldman, S. R. Skin disease in children: effects on quality of life, stigmatization, bullying, and suicide risk in pediatric acne, atopic dermatitis, and psoriasis patients. Children 8, 1057 (2021).","journal-title":"Children"},{"key":"29772_CR38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1590\/S0365-05962010000500005","volume":"85","author":"JR Faria","year":"2010","unstructured":"Faria, J. R., Aar\u00e3o, A. R., Jimenez, L. M., Silva, O. H. & Avelleira, J. C. Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index). An. Bras. Dermatol. 85, 625\u2013629 (2010).","journal-title":"An. Bras. Dermatol."},{"key":"29772_CR39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10916-018-1110-7","volume":"42","author":"C Fink","year":"2018","unstructured":"Fink, C., Fuchs, T., Enk, A. & Haenssle, H. A. Design of an algorithm for automated, computer-guided PASI measurements by digital image analysis. J. Med. Syst. 42, 248 (2018).","journal-title":"J. Med. Syst."},{"key":"29772_CR40","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41419-023-06234-9","volume":"14","author":"C Ma","year":"2023","unstructured":"Ma, C. et al. Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling. Cell Death Dis. 14, 768. https:\/\/doi.org\/10.1038\/s41419-023-06234-9 (2023).","journal-title":"Cell Death Dis."},{"key":"29772_CR41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen, M. et al. Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12, 789 (2020).","journal-title":"Pharmaceutics"},{"key":"29772_CR42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamadermatol.2019.4835","volume":"156","author":"IM Bronckers","year":"2020","unstructured":"Bronckers, I. M. et al. A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents. JAMA Dermatol. 156, 384\u2013392 (2020).","journal-title":"JAMA Dermatol."},{"key":"29772_CR43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/ijd.IJD_492_20","volume":"66","author":"S Banerjee","year":"2021","unstructured":"Banerjee, S., Das, S., Roy, A. K. & Ghoshal, L. Comparative effectiveness and safety of methotrexate versus PUVA in severe chronic stable plaque psoriasis. Indian J. Dermatol. 66, 371\u2013377 (2021).","journal-title":"Indian J. Dermatol."},{"key":"29772_CR44","doi-asserted-by":"crossref","first-page":"558629","DOI":"10.3389\/fphar.2020.558629","volume":"11","author":"J Zong","year":"2020","unstructured":"Zong, J. et al. Serum metabolomic profiling reveals the amelioration effect of methotrexate on imiquimod-induced psoriasis in mouse. Front. Pharmacol. 11, 558629 (2020).","journal-title":"Front. Pharmacol."},{"key":"29772_CR45","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1208\/s12248-017-0094-4","volume":"19","author":"C Soderstrom","year":"2017","unstructured":"Soderstrom, C. et al. Ultra-sensitive measurement of IL-17A and IL-17F in psoriasis patient serum and skin. AAPS J. 19, 1218\u20131222 (2017).","journal-title":"AAPS J."},{"key":"29772_CR46","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3389\/fimmu.2019.03096","volume":"10","author":"E von Stebut","year":"2020","unstructured":"von Stebut, E. et al. IL-17A in psoriasis and beyond: Cardiovascular and metabolic implications. Front. Immunol. 10, 3096 (2020).","journal-title":"Front. Immunol."},{"key":"29772_CR47","doi-asserted-by":"crossref","first-page":"819149","DOI":"10.1155\/2015\/819149","volume":"2015","author":"PS Oliveira","year":"2015","unstructured":"Oliveira, P. S. et al. IL-17A, IL-22, IL-6, and IL-21 serum levels in plaque-type psoriasis in Brazilian patients. Mediat. Inflamm. 2015, 819149 (2015).","journal-title":"Mediat. Inflamm."},{"key":"29772_CR48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00005-018-0527-5","volume":"67","author":"B Wawrzycki","year":"2019","unstructured":"Wawrzycki, B. et al. Interleukin-22 and its correlation with disease activity in plaque psoriasis. Arch. Immunol. Ther. Exp. 67, 103\u2013108 (2019).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"29772_CR49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00403-017-1735-2","volume":"309","author":"N Shimoura","year":"2017","unstructured":"Shimoura, N. et al. Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia. Arch. Dermatol. Res. 309, 315\u2013321 (2017).","journal-title":"Arch. Dermatol. Res."},{"key":"29772_CR50","doi-asserted-by":"crossref","first-page":"e01130","DOI":"10.1002\/prp2.1130","volume":"11","author":"F Calapai","year":"2023","unstructured":"Calapai, F. et al. Suspected oncologic adverse reactions associated with interleukin-23 inhibitors in EudraVigilance: Comparative study and gender distribution. Pharmacol. Res. Perspect. 11, e01130 (2023).","journal-title":"Pharmacol. Res. Perspect."},{"key":"29772_CR51","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1038\/s41598-021-89925-7","volume":"11","author":"E Tarentini","year":"2021","unstructured":"Tarentini, E. et al. Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis. Sci. Rep. 11, 10472 (2021).","journal-title":"Sci. Rep."},{"key":"29772_CR52","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1002\/iid3.1104","volume":"11","author":"Z Tu","year":"2023","unstructured":"Tu, Z. et al. Pro-inflammatory cytokine IL-6 regulates LMO4 expression in psoriatic keratinocytes via AKT\/STAT3 pathway. Immun. Inflamm. Dis. 11, e1104 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"29772_CR53","doi-asserted-by":"crossref","first-page":"11662","DOI":"10.3390\/ijms241411662","volume":"24","author":"B-W Lee","year":"2023","unstructured":"Lee, B.-W. & Moon, S.-J. Inflammatory cytokines in psoriatic arthritis: Understanding pathogenesis and implications for treatment. Int. J. Mol. Sci. 24, 11662 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR54","first-page":"3843","volume":"398 (4)","author":"W Chen","year":"2024","unstructured":"Chen, W., Ge, L. & Zhang, C. The molecular mechanism of berberine affecting psoriasis skin inflammation by regulating keratinocyte pyroptosis via the p38 MAPK\/NF-\u03baB pathway. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 398, 1\u201317 (2024).","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"29772_CR55","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/ijms23042112","volume":"23","author":"H Guo","year":"2022","unstructured":"Guo, H., Li, M. & Liu, H. Selenium-rich yeast peptide fraction ameliorates imiquimod-induced psoriasis-like dermatitis in mice by inhibiting inflammation via MAPK and NF-\u03baB signaling pathways. Int. J. Mol. Sci. 23, 2112 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR56","doi-asserted-by":"crossref","first-page":"107754","DOI":"10.1016\/j.intimp.2021.107754","volume":"96","author":"R Sangaraju","year":"2021","unstructured":"Sangaraju, R., Alavala, S., Nalban, N., Jerald, M. K. & Sistla, R. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB\/c mice via down regulating NF-\u03baB and activation of Nrf2 signaling pathways. Int. Immunopharmacol. 96, 107754 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"29772_CR57","doi-asserted-by":"crossref","first-page":"14197","DOI":"10.3390\/ijms241814197","volume":"24","author":"M Yoshida","year":"2023","unstructured":"Yoshida, M., Funasaka, Y., Saeki, H., Yamamoto, M. & Kanda, N. Dietary fiber inulin improves murine imiquimod-induced psoriasis-like dermatitis. Int. J. Mol. Sci. 24, 14197 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117115","volume":"241","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model. Life Sci. 241, 117115. https:\/\/doi.org\/10.1016\/j.lfs.2019.117115 (2020).","journal-title":"Life Sci."},{"key":"29772_CR59","doi-asserted-by":"publisher","first-page":"e10109","DOI":"10.1590\/1414-431x202010109","volume":"53","author":"J Fu","year":"2020","unstructured":"Fu, J., Zeng, Z., Zhang, L., Wang, Y. & Li, P. 4\u2019-O-\u03b2-D-glucosyl-5-O-methylvisamminol ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production by suppressing the NF-\u03baB and MAPK signaling pathways. Braz. J. Med. Biol. Res. Revista brasileira de pesquisas medicas e biologica 53, e10109. https:\/\/doi.org\/10.1590\/1414-431x202010109 (2020).","journal-title":"Braz. J. Med. Biol. Res. Revista brasileira de pesquisas medicas e biologica"},{"key":"29772_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322710","volume":"20","author":"X Huang","year":"2025","unstructured":"Huang, X. et al. Broussonetia papyrifera ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by modulating the TLR4\/NF-\u03baB and PI3K\/AKT signaling pathways. PLoS ONE 20, e0322710. https:\/\/doi.org\/10.1371\/journal.pone.0322710 (2025).","journal-title":"PLoS ONE"},{"key":"29772_CR61","unstructured":"Elango, T. et al. In: Psoriasis-New Research (IntechOpen, 2022)."},{"key":"29772_CR62","doi-asserted-by":"crossref","first-page":"10132","DOI":"10.3390\/ijms241210132","volume":"24","author":"N Cuesta-Gomez","year":"2023","unstructured":"Cuesta-Gomez, N., Medina-Ruiz, L., Graham, G. J. & Campbell, J. D. IL-6 and TGF-\u03b2-secreting adoptively-transferred murine mesenchymal stromal cells accelerate healing of psoriasis-like skin inflammation and upregulate IL-17A and TGF-\u03b2. Int. J. Mol. Sci. 24, 10132 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"29772_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cca.2015.10.020","volume":"451","author":"T Elango","year":"2015","unstructured":"Elango, T., Thirupathi, A., Subramanian, S., Dayalan, H. & Gnanaraj, P. Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients. Clin. Chim. Acta 451, 329\u2013337. https:\/\/doi.org\/10.1016\/j.cca.2015.10.020 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"29772_CR64","doi-asserted-by":"crossref","first-page":"173088","DOI":"10.1016\/j.ejphar.2020.173088","volume":"877","author":"NO Al-Harbi","year":"2020","unstructured":"Al-Harbi, N. O. et al. Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells. Eur. J. Pharmacol. 877, 173088 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"29772_CR65","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s10753-023-01805-6","volume":"46","author":"Y He","year":"2023","unstructured":"He, Y. et al. Specific activation of CB2R ameliorates psoriasis-like skin lesions by inhibiting inflammation and oxidative stress. Inflammation 46, 1255\u20131271 (2023).","journal-title":"Inflammation"},{"key":"29772_CR66","first-page":"100846","volume":"18","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Nano transdermal system combining mitochondria-targeting cerium oxide nanoparticles with all-trans retinoic acid for psoriasis. Asian J. Pharm. Sci. 18, 100846 (2023).","journal-title":"Asian J. Pharm. Sci."},{"key":"29772_CR67","first-page":"2020047","volume":"40","author":"A Liu","year":"2020","unstructured":"Liu, A. et al. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-\u03baB\/MAPK pathway. Biosci. Rep. 40, 2020047 (2020).","journal-title":"Biosci. Rep."},{"key":"29772_CR68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13510002.2019.1658377","volume":"24","author":"F Xu","year":"2019","unstructured":"Xu, F., Xu, J., Xiong, X. & Deng, Y. Salidroside inhibits MAPK, NF-\u03baB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation. Redox Rep. Commun. Free Radic. Res. 24, 70\u201374. https:\/\/doi.org\/10.1080\/13510002.2019.1658377 (2019).","journal-title":"Redox Rep. Commun. Free Radic. Res."},{"key":"29772_CR69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11418-022-01664-9","volume":"77","author":"Y Xiong","year":"2023","unstructured":"Xiong, Y., Wang, J., Wang, S., Li, H. & Zhou, X. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-\u03baB\/MAPK\/Nrf2 pathways. J. Nat. Med. 77, 188\u2013201 (2023).","journal-title":"J. Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29772-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29772-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29772-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:16:02Z","timestamp":1767622562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29772-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29772"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29772-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"337"}}